ADVENTRX Pharmaceuticals, Inc. Form 8-K Dated November 15, 2004

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
 

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported) November 15, 2004

ADVENTRX Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of incorporation)


001-32157
(Commission File Number)
  
84-1318182
(IRS Employer Identification No.)


6725 Mesa Ridge Road, Suite 100
San Diego, California 92121
(Address of principal executive offices) (Zip Code)


(858) 552-0866
(Company’s telephone number, including area code)

 
     
 

Item 2.02. Results of Operations and Financial Condition.

On November 15, 2004, ADVENTRX Pharmaceuticals, Inc. issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2004. A copy of this press release is furnished as Exhibit 99.1 to this report and is incorporated into this Form 8-K by reference.

Item 9.01. Financial Statements and Exhibits.
 
(c) The exhibit list required by this item is incorporated by reference to the Exhibit Index filed as part of this report.

     
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  ADVENTRX Pharmaceuticals, Inc.
 
 		  
 		  
 
  By:   /s/ Steven M. Plumb
 
 
Name:  Steven M. Plumb, CPA
  Title:  Chief Financial Officer
   
 
November 15, 2004

 
     
 
EXHIBIT INDEX

Exhibit
Description
   
Press Release of the Company dated November 15, 2004.